Literature DB >> 20467846

(11)C-Methionine PET/CT for multiple myeloma.

Masatoshi Nishizawa1, Yuji Nakamoto, Tsuyoshi Suga, Toshiyuki Kitano, Takayuki Ishikawa, Kouhei Yamashita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20467846     DOI： 10.1007/s12185-010-0595-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  1 in total

1.  Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience.

Authors:  Anja Dankerl; Peter Liebisch; Gerhard Glatting; Claudia Friesen; Norbert M Blumstein; Darius Kocot; Christiane Wendl; Donald Bunjes; Sven N Reske
Journal:  Radiology       Date:  2006-12-19       Impact factor: 11.105
  1 in total
  5 in total

1.  Whole-body MRI and PET/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study.

Authors:  Giuseppe Lucio Cascini; Carmela Falcone; Domenico Console; Antonino Restuccia; Marco Rossi; Antonello Parlati; Oscar Tamburrini
Journal:  Radiol Med       Date:  2013-06-26       Impact factor: 3.469

Review 2.  Molecular imaging in myeloma precursor disease.

Authors:  Esther Mena; Peter Choyke; Esther Tan; Ola Landgren; Karen Kurdziel
Journal:  Semin Hematol       Date:  2011-01       Impact factor: 3.851

3.  Clinical value of ¹¹C-methionine PET/CT in patients with plasma cell malignancy: comparison with ¹⁸F-FDG PET/CT.

Authors:  Yuji Nakamoto; Kensuke Kurihara; Masatoshi Nishizawa; Kouhei Yamashita; Koya Nakatani; Tadakazu Kondo; Akifumi Takaori-Kondo; Kaori Togashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-23       Impact factor: 9.236

4.  Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma.

Authors:  Momoko Okasaki; Kazuo Kubota; Ryogo Minamimoto; Yoko Miyata; Miyako Morooka; Kimiteru Ito; Kiichi Ishiwata; Jun Toyohara; Tomio Inoue; Risen Hirai; Shotaro Hagiwara; Akiyoshi Miwa
Journal:  Ann Nucl Med       Date:  2014-11-25       Impact factor: 2.668

5.  11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma.

Authors:  Katharina Lückerath; Constantin Lapa; Christa Albert; Ken Herrmann; Gerhard Jörg; Samuel Samnick; Herrmann Einsele; Stefan Knop; Andreas K Buck
Journal:  Oncotarget       Date:  2015-04-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.